According to the Financial Times (FT), the recent changing of the guard at several big drugmakers, including Pfizer, the world’s largest, may make it easier for drug industry lobbyists to woo democrats.

“Democrats may be more willing to lend an ear to chief executive Jeffrey Kindler than former chief executive Hank McKinnell, who was a large donor to the Republican party,” reported FT (see “Big Pharma on a mission to woo Democrats“).

FT went on to report “Records collected by the Center for Responsive Politics show that Mr Kindler donated $10,200 in this election cycle. The beneficiaries were all Democrats.”

That’s about 0.2% of the $4.5 million Pharma donated to Democratic candidates (vs. $10 million lavished on Republicans). Some hedge bet!

Mr. Kindler’s largesse notwithstanding, the drug industry is marshaling its forces to defend its gains. As I mentioned in yesterday’s post (see “What’s In Store from Congress?“), there are several proposed legislative changes that the industry is anticipating it must fight. What’s your opinion?

Take the Pharma Marketing News Online Survey
Pharma Marketing News is currently hosting an online survey to determine how likely these changes are according to pharmaceutical marketing experts. You can take the survey here. You will be able to see a de-identified summary of the current results after you complete the survey. I plan to also write up a summary of the results for the December issue of the newsletter. Your responses are held strictly confidential unless you give me permission to use your name.